|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 33 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-25 |
4/A |
S |
$26.94 |
$26,944 |
D/D |
(1,000) |
130,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-27 |
4 |
S |
$28.00 |
$8,120 |
D/D |
(290) |
129,803 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-06-06 |
4 |
S |
$27.39 |
$54,772 |
D/D |
(2,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-02 |
4 |
S |
$30.23 |
$242,136 |
D/D |
(8,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-12 |
4 |
S |
$27.10 |
$81,288 |
D/D |
(3,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-19 |
4 |
S |
$26.75 |
$53,496 |
D/D |
(2,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-30 |
4 |
S |
$29.01 |
$58,018 |
D/D |
(2,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-02-23 |
4 |
S |
$35.31 |
$176,541 |
D/D |
(5,000) |
121,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-02-29 |
4 |
S |
$36.26 |
$36,258 |
D/D |
(1,000) |
115,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-03-08 |
4 |
S |
$35.00 |
$35,000 |
D/D |
(1,000) |
114,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-03-09 |
4 |
S |
$34.46 |
$516,867 |
D/D |
(15,000) |
114,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-11 |
4 |
S |
$38.01 |
$969,656 |
D/D |
(25,500) |
168,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-14 |
4 |
S |
$38.13 |
$571,893 |
D/D |
(15,000) |
168,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-09-14 |
4 |
S |
$37.91 |
$151,628 |
D/D |
(4,000) |
177,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-11-07 |
4 |
S |
$47.00 |
$236,470 |
D/D |
(5,000) |
169,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-11-09 |
4 |
S |
$48.42 |
$96,844 |
D/D |
(2,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-11-14 |
4 |
S |
$48.50 |
$193,987 |
D/D |
(4,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-11-16 |
4 |
S |
$48.05 |
$384,366 |
D/D |
(8,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-12-04 |
4 |
S |
$47.94 |
$239,692 |
D/D |
(5,000) |
167,691 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-02-27 |
4 |
S |
$56.46 |
$84,683 |
D/D |
(1,500) |
120,401 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-04-30 |
4 |
S |
$63.74 |
$63,742 |
D/D |
(1,000) |
119,317 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-02 |
4 |
S |
$65.62 |
$131,241 |
I/I |
(2,000) |
13,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-14 |
4 |
S |
$70.17 |
$1,052,492 |
I/I |
(15,000) |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-14 |
4 |
S |
$70.74 |
$1,773,551 |
I/I |
(25,000) |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-08-15 |
4 |
S |
$64.36 |
$64,364 |
I/I |
(1,000) |
48,740 |
0 |
- |
|
850 Records found
|
|
Page 33 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|